The University of Science and Technology of China
9
2
2
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Autologous Decidual-like Natural Killer Cells Therapy for Reproductive Failure
Role: collaborator
Autologous Decidual-like Natural Killer Cells Therapy for Infertility or Adverse Pregnancy History
Role: collaborator
Clinical Study of Vitamin B5 in Adjuvant Treatment of IBD
Role: collaborator
Syndrome Patterns for Chronic Atrophic Gastritis Malignant Transformation
Role: collaborator
Risk Assessment and Syndrome Evolution Models for Chronic Atrophic Gastritis Malignant Transformation
Role: collaborator
NK Cell Infusion for Patients With Acute Myeloid Leukemia
Role: collaborator
Multi-center Imaging Genetics Studies in China
Role: collaborator
Point-of-Care Bedside Lung Ultrasound Examination Advanced Trial Protocol
Role: collaborator
Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and Hypertension
Role: collaborator
All 9 trials loaded